News edition
Issue 2026-11-15
6 stories

U.S. Department of Energy Genesis Mission Unveils ORBIT Water-Energy AI Platform and Grid Scaling Roadmap for Data Center Demand
Oak Ridge National Laboratory leads the exascale-trained ORBIT AI foundation platform cutting hydro-meteorological simulations from days to seconds, as DOE targets 20-to-100-fold faster grid planning decisions.

U.S. Department of Energy Mobilizes Subsurface Digital Twins for Geothermal and Strategic Assets Across 33 National Science Challenges
Under its Genesis Mission, DOE is pairing physics-informed machine learning with national laboratory simulation suites to unlock fractured geothermal and hydrocarbon reservoirs within a five-pillar, 33-challenge national S&T portfolio.

IMF Outlines ASEAN AI and Capital Market Frontier in Manila as U.S. Banking Regulators Extend Third-Party Risk Guidance Review
At the 49th ASEAN Summit, IMF Managing Director Kristalina Georgieva highlighted 4.9% regional growth and a 4.3% GDP upside from cutting nontariff barriers, while four U.S. financial agencies extended third-party vendor risk comments to December 16.

COP31 Reaches Midpoint in Antalya as UN Climate Chief Urges Party Compromise and Guterres Calls for 6% Annual Emissions Cuts
UN Climate Change Executive Secretary Simon Stiell pressed nearly 200 countries working through 165 COP31 mandates to avoid tactical delays, following UN Secretary-General António Guterres's final COP warning on inevitable 1.5°C overshoot.

U.S. October Wholesale Inflation Reaches 6.5% Annual Pace on Freight Costs as Census Bureau Expands Household and Workforce Tracking
The Bureau of Labor Statistics reported a 0.3% monthly rise in October final demand PPI and the largest 12-month gain since November 2022, while the U.S. Census Bureau released 136,000-household pulse data on employment and energy bills.

WHO Issues First Global Guidelines on Adult Type 1 Diabetes as European Medicines Agency Recommends Two Insulin Aspart Biosimilars
Marking World Diabetes Day 2026, WHO released its first clinical framework for adult type 1 diabetes across low-resource and humanitarian settings, one day after EMA's CHMP backed seven new medicines including two insulin biosimilars.